-
Research
-
- Funding & Notices
- News & Media
- About Translation
-
- About NCATS
-
NCATS Programs & Initiatives
- 3-D Tissue Bioprinting Program
- Stem Cell Translation Laboratory
- Assay Development and Screening Technology (ADST)
- Biomedical Data Translator
- Bridging Interventional Development Gaps (BrIDGs)
- Chemistry Technology
- Discovering New Therapeutic Uses for Existing Molecules
- Genetic and Rare Diseases Information Center (GARD)
- Matrix Combination Screening
- Early Translation Branch (ETB)
- A Specialized Platform for Innovative Research Exploration (ASPIRE)
- A Translational Approach to Addressing COVID-19
- Antiviral Program for Pandemics
- Clinical Trial Readiness for Rare Diseases, Disorders and Syndromes
- Multidisciplinary Machine-Assisted, Genomic Analysis and Clinical Approaches to Shortening the Rare Diseases Diagnostic Odyssey
- National COVID Cohort Collaborative (N3C)
- The Accelerating Medicines Partnership® Bespoke Gene Therapy Consortium (BGTC)
- NIH Common Fund Programs
- Rare Diseases Registry Program (RaDaR)
- Tissue Chip for Drug Screening
- Toxicology in the 21st Century (Tox21)
- Functional Genomics Lab
- Therapeutics for Rare and Neglected Diseases (TRND)
- About NCATS
- Home
- News & Media
- News & Events
- Releases & Announcements
- Releases & Announcements 2021
Releases & Announcements 2021
January 2021
-
DNA-Editing Method Shows Promise to Treat Mouse Model of Progeria
NCATS, NHGRI ∙ 01/06/2021 ∙ Somatic Cell Genome Editing
March 2021
-
NCATS Director Statement in Support of Ending Structural Racism and Health Disparities
NCATS ∙ 03/01/2021 ∙ Director's Statement -
Assessing a Compound’s Activity, Not Just Its Structure, Could Deepen the Pool of Promising Drug Therapies
NCATS ∙ 03/03/2021 ∙ Division of Preclinical Innovation -
NIH Statement on the Departure of Dr. Christopher Austin
The NIH Director ∙ 03/18/2021 ∙ NCATS, NIH -
Dr. Christopher P. Austin to Step Down as NCATS Director
NCATS ∙ 03/18/2021 ∙ Director's Statement
April 2021
-
NIH-Funded Research Team Develops Language Test for People with Down Syndrome
NCATS, NICHD ∙ 04/08/2021 ∙ CTSA Program -
Drug Testing Approach Uncovers Effective Combination for Treating Small Cell Lung Cancer
NCATS ∙ 04/12/2021 ∙ Division of Preclinical Innovation -
Large Clinical Trial to Study Repurposed Drugs to Treat COVID-19 Symptoms
NCATS ∙ 04/19/2021 ∙ CTSA Program -
Dr. Andrew Singleton to Direct New NIH Research Laboratory for Alzheimer’s and Related Dementias Research
NCATS, NIA ∙ 04/26/2021 ∙ Division of Preclinical Innovation
May 2021
-
Scientists Identify Small-Molecule Cocktail to Improve Stem Cell Use in Research and Disease Treatments
NCATS ∙ 05/03/2021 ∙ Stem Cell Translation Laboratory
June 2021
-
NIH Study Suggests COVID-19 Prevalence Far Exceeded Early Pandemic Cases
NIBIB ∙ 06/22/2021 ∙ CTSA Program -
Study Links Sleep Apnea in Children to Increased Risk of High Blood Pressure in Teen Years
NCATS, NHLBI ∙ 06/23/2021 ∙ CTSA Program
July 2021
-
More than Two Hours of Daily Screen Time Linked to Cognitive, Behavioral Problems in Children Born Extremely Preterm
NCATS, NICHD ∙ 07/15/2021 ∙ CTSA Program
October 2021
-
Oxytocin Does Not Improve Social Functioning in Children with Autism Spectrum Disorder, NIH-Funded Study Suggests
NICHD ∙ 10/13/2021 ∙ CTSA Program -
NIH Study Suggests People with Rare Diseases Face Significantly Higher Health Care Costs
NCATS ∙ 10/22/2021 ∙ Rare Diseases -
NIH, FDA and 15 Private Organizations Join Forces to Increase Effective Gene Therapies for Rare Diseases
NCATS, NIH ∙ 10/27/2021 ∙ Bespoke Gene Therapy Consortium
- Funding & Notices
-